Atrial Fibrillation Clinical Trials in Daejeon
2 recruitingDaejeon, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Phase 2
Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
Atrial FibrillationStrokeMitral Valve Stenosis+1 more
Sung-Hwan Kim240 enrolled7 locationsNCT05540587